Clicky

Takeda Pharmaceutical Company Limited(TAK) News

Date Title
May 9 Takeda Pharmaceutical Projects Lower Annual Profit After Quarterly Loss
May 9 Takeda Announces FY2023 Full Year Results and FY2024 Outlook, Affirming Commitment to Late-Stage Pipeline Development and Core Operating Profit Margin Expansion
May 8 Protagonist Therapeutics Inc (PTGX) Surpasses Q1 Revenue Estimates with Strategic Collaborations
Apr 29 Down -6.19% in 4 Weeks, Here's Why Takeda Pharmaceutical Co. (TAK) Looks Ripe for a Turnaround
Apr 26 Down -5.9% in 4 Weeks, Here's Why Takeda Pharmaceutical Co. (TAK) Looks Ripe for a Turnaround
Apr 26 HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda
Apr 26 Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer
Apr 25 All You Need to Know About Takeda Pharmaceutical Co. (TAK) Rating Upgrade to Strong Buy
Apr 25 TAK or CTLT: Which Is the Better Value Stock Right Now?
Apr 25 20 Fastest Growing Health Tech Companies in the World
Apr 25 New Strong Buy Stocks for April 25th
Apr 25 Best Value Stocks to Buy for April 25th
Apr 25 Best Income Stocks to Buy for April 25th
Apr 23 Takeda Pharmaceutical: A Long-Term Cash Cow
Apr 23 Neurocrine Biosciences Reports Positive Phase 2 Data for NBI-1065845 in Adults with Major Depressive Disorder
Apr 22 Pharmas form joint venture to jumpstart Japanese drug research
Apr 22 Takeda, Astellas and Sumitomo Mitsui Banking Announce Master Agreement to Establish Joint Venture Company for Incubation of Early Drug Discovery Programs
Apr 19 MasterCraft Boat, SentinelOne, and More Stocks See Action From Activist Investors
Apr 18 U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
Apr 8 Takeda Announces New U.S. Corporate Social Responsibility Program Partners to Build Equity through STEM Education and Access to Nutritional Food